Master RBC membrane proteins, lipid bilayer structure, and their clinical significance for ASCP hematology questions.
Chapter 3 โ RBC METABOLISM & MEMBRANE STRUCTURE
1 ยท Priority Table & Quick Foundation
| Topic | Priority | Why It’s Tested |
|---|---|---|
| The four metabolic pathways โ product and purpose of each | HIGH | ‘Which pathway generates ATP / NADPH / 2,3-BPG / keeps iron ferrous?’ is a guaranteed item |
| HMP shunt, G6PD, glutathione, Heinz bodies | HIGH | G6PD deficiency is the most common inherited RBC enzyme defect worldwide |
| Methemoglobin reductase (cytochrome b5 reductase) & cyanosis | HIGH | Cyanosis case questions; NADH vs NADPH confusion |
| Rapoport-Luebering shunt & 2,3-BPG (Oโ release, ATP cost) | HIGH | Links to the oxygen dissociation curve and altitude/anemia adaptation |
| Vertical vs horizontal membrane linkages โ hereditary spherocytosis vs elliptocytosis | HIGH | Mechanism questions for the two commonest membrane disorders |
| Transmembrane (integral) vs skeletal (peripheral) proteins | HIGH | ‘Which is an integral protein?’ โ glycophorin A vs ankyrin/spectrin/actin |
| Osmotic balance: cation pumps, Naโบ/Kโบ gradients, colloid osmotic hemolysis | HIGH | Explains why ATP failure โ spherocytes โ hemolysis |
| GPI anchor, CD55/CD59, PIGA โ PNH | HIGH | Flow cytometry diagnosis of PNH is a classic board topic |
| Lipid asymmetry, flippases, PS exposure; cholesterol exchange โ target cells/acanthocytes | MEDIUM | Senescence signal and acquired shape changes |
| Deformability determinants (surface area, MCHC/viscosity, elasticity) | MEDIUM | Why high MCHC or spheres shorten survival |
| Blood-group-bearing proteins (GPA MN, GPB Ss, GPC Gerbich, Rh/RhAG, Kell, Duffy, Kidd) | MEDIUM | Crossover with blood bank; RhAG โ Rh-null |
| Glycolysis enzyme sequence (hexokinase, PFK, PK, etc.) | MEDIUM | PK deficiency; ATP-consuming vs ATP-generating steps |
| SDS-PAGE band numbering, molecular weights, copy numbers | LOW | Recall only that lower band number = higher molecular weight |
| Individual phospholipid chemistry, spectrin repeat counts | LOW | Not tested beyond outer vs inner leaflet |
Focus: one product + one purpose + one disease for each pathway; vertical (โ spherocytes) vs horizontal (โ elliptocytes); integral vs skeletal proteins; the Naโบ/Kโบ/Caยฒโบ pump story; GPI-anchored CD55/CD59 and PNH. Skim: molecular weights, copy numbers, spectrin repeats, and every glycolytic intermediate past the key enzymes.
Quick Foundation โ from zero
- A mature RBC has no nucleus, no mitochondria, no ribosomes (lost 24โ48 h after release). It can’t make proteins or burn fuel with oxygen.
- Its only energy source is anaerobic glycolysis of plasma glucose, which enters through Glut-1 without spending energy (no insulin needed).
- Carrying Oโ and COโ is passive. What needs energy is protecting the cell: pumping ions, keeping hemoglobin iron ferrous, fighting oxidants, and keeping the membrane flexible.
- Three side roads branch off glycolysis: the HMP shunt (antioxidant NADPH), the methemoglobin reductase pathway (keeps iron Feยฒโบ), and the Rapoport-Luebering shunt (makes 2,3-BPG to unload Oโ).
- The membrane is a lipid bilayer (barrier) stitched onto a protein net underneath (skeleton). Transmembrane proteins pin the bilayer to the skeleton โ the vertical links. Spectrin-to-spectrin links make the net โ the horizontal links.
- Lose vertical links โ the bilayer flakes off โ spherocytes. Weaken horizontal links โ the net can’t spring back โ elliptocytes.
- When ATP runs out, pumps fail, Naโบ and water rush in, the cell rounds up and bursts (colloid osmotic hemolysis).
The RBC is a tent. The fabric is the lipid bilayer; the poles and ropes underneath are spectrin and actin (horizontal frame); the stakes that nail the fabric to the frame are band 3โankyrin and glycophorin Cโ4.1 (vertical). Pull out the stakes and pieces of fabric blow away โ the tent shrinks into a ball (spherocyte). Snap the ropes and the frame sags into an oval (elliptocyte). The generator (glycolysis) runs the pumps that keep the tent from flooding.
Most inherited hemolytic anemias are either an enzyme defect (G6PD, PK โ often normal shape, ‘nonspherocytic’) or a membrane defect (HS, HE). Knowing which pathway or linkage failed tells you which test to order.
| Concept | Plain-English Explanation |
|---|---|
| Anaerobic glycolysis (EMP) | Glucose โ lactate without oxygen; the RBC’s only ATP source |
| NADPH vs NADH | NADPH (from HMP/G6PD) fights peroxide via glutathione; NADH (from glycolysis) reduces methemoglobin |
| Methemoglobin | Hemoglobin with iron in the ferric (Feยณโบ) state โ can’t carry Oโ |
| 2,3-BPG | Small molecule that makes Hb let go of Oโ in the tissues |
| Integral (transmembrane) protein | Crosses the bilayer (band 3, glycophorins); carries antigens and transports |
| Peripheral (skeletal) protein | Lies under the bilayer only (spectrin, ankyrin, actin, 4.1) |
| Semipermeable membrane | Lets water and some small anions through; blocks cations and large molecules |
| GPI anchor | Lipid ‘hook’ holding ~30 proteins (incl. CD55, CD59) on the outer surface |
2 ยท Core Content Tables
2.1 Energy Needs of the RBC
| Feature | Details |
|---|---|
| Processes that REQUIRE energy | Cation gradient maintenance ยท phospholipid asymmetry ยท skeletal protein deformability ยท keeping Hb iron ferrous ยท protecting proteins from oxidative denaturation ยท starting glycolysis ยท glutathione synthesis ยท nucleotide salvage |
| Process that does NOT require energy | Oxygen (and COโ) transport โ passive binding and release by hemoglobin |
| Glucose entry | Glut-1 transmembrane protein; no energy; independent of insulin |
| Why no reserve | No glycogen, no mitochondria โ depends minute-to-minute on plasma glucose |
| Clinical significance | As enzymes decay, ATP falls โ cell becomes senescent and is removed (~120 days). Inherited glycolytic enzyme defects โ hereditary nonspherocytic hemolytic anemia |
2.2 Embden-Meyerhof Pathway (Anaerobic Glycolysis)
| Feature | Details |
|---|---|
| Share of glucose | ~90% (McKenzie: 90โ95%) |
| ATP balance | Consumes 2 ATP (hexokinase, phosphofructokinase) ยท generates 4 ATP (phosphoglycerate kinase ร2, pyruvate kinase ร2) ยท net +2 ATP per glucose |
| Phase 1 | Glucose โ G6P (hexokinase) โ F6P (G6P isomerase) โ F1,6-BP (PFK) โ G3P + DHAP (aldolase). Hexokinase and PFK steps limit the rate |
| Phase 2 | G3P โ 1,3-BPG (G3PD, generates NADH) โ 3-PG + 2 ATP (phosphoglycerate kinase) |
| Phase 3 | 3-PG โ 2-PG (mutase) โ PEP (enolase) โ pyruvate + 2 ATP (pyruvate kinase). PK is activated allosterically by F1,6-BP |
| End step | Pyruvate โ lactate (lactate dehydrogenase) regenerates NADโบ so glycolysis can continue; lactate/pyruvate leave the cell |
| Clinical significance | PK deficiency = most common glycolytic enzyme defect โ โ ATP โ rigid, dehydrated cells โ chronic hemolysis (often โ 2,3-BPG upstream, so anemia is tolerated relatively well)* |
Glycolysis is the RBC’s generator. Everything else in this chapter either branches off it (shunts) or runs on its ATP (pumps, flippases, skeleton).
- EDTA or heparin whole blood; test before transfusion or wait ~3 months after (donor cells mask deficiency)*
- Remove leukocytes and platelets (filtration) โ WBCs have high PK activity and can falsely normalize the result*
- High reticulocyte counts raise enzyme activity (young cells) โ interpret against the retic count*
2.3 Hexose Monophosphate Shunt (Pentose Phosphate / Aerobic Glycolysis)
| Feature | Details |
|---|---|
| Share of glucose | 5โ10% of G6P at rest; can rise up to ~30-fold during oxidative challenge |
| Key enzymes | G6PD (G6P โ 6-phosphogluconate, NADPโบ โ NADPH) โ 6-phosphogluconate dehydrogenase (โ ribulose-5-P + COโ + NADPH). Pentoses re-enter glycolysis |
| Mechanism of protection | NADPH โ glutathione reductase converts GSSG โ GSH โ glutathione peroxidase reduces HโOโ โ HโO. Protects heme iron, globin โSH groups, enzymes, and membrane lipids/thiols |
| Unique role | G6PD is the only source of NADPH in the RBC |
| When it fails | Peroxide oxidizes Hb โ denatured Hb precipitates as Heinz bodies on the inner membrane โ splenic macrophages remove them (‘bite cells’) or the whole cell โ hemolysis. Membrane โSH oxidation โ leaky membranes |
| Triggers in G6PD deficiency | Oxidant drugs (primaquine, sulfonamides, dapsone), infection, fava beans |
| Clinical significance | G6PD deficiency = most common inherited RBC enzyme deficiency worldwide; X-linked* โ mostly males; episodic hemolysis |
- Fluorescent spot test (screen): NADPH fluoresces under UV โ deficient blood fails to fluoresce; quantitative spectrophotometric assay confirms
- EDTA/heparin/ACD whole blood; avoid testing during or right after a hemolytic episode (old deficient cells destroyed; retics have more G6PD โ false normal) and after transfusion โ repeat in ~2โ3 months*
- Heinz bodies need a supravital stain (crystal violet, brilliant cresyl blue) โ invisible on Wright stain
- Heterozygous females can be missed by screening tests because of mixed normal/deficient populations*
2.4 Methemoglobin Reductase Pathway
| Feature | Details |
|---|---|
| Why needed | Heme iron is constantly oxidized by Oโ and peroxide from Feยฒโบ to Feยณโบ (methemoglobin), which cannot bind Oโ. The HMP prevents oxidation but can’t efficiently reverse it |
| Enzyme | Methemoglobin reductase = cytochrome b5 reductase (NADH diaphorase) |
| Mechanism | Uses NADH generated when G3P โ 1,3-BPG (G3PD step) โ electron carrier cytochrome b5 โ returns Feยณโบ to Feยฒโบ. Provides >65% of MetHb-reducing capacity. NADPH can reduce MetHb only slowly |
| Normal load | ~2% of Hb oxidized daily; without the pathway MetHb would accumulate to 20โ40% (McKenzie) |
| Clinical significance | Hereditary cytochrome b5 reductase deficiency (autosomal recessive โ e.g., affected brothers) or oxidant drugs/chemicals (nitrites, dapsone, local anesthetics*) โ methemoglobinemia โ cyanosis despite normal PaOโ, chocolate-brown blood |
| Treatment clue | Ascorbic acid (vitamin C), a reducing agent, reduces MetHb non-enzymatically โ it turned Deeny’s ‘blue men’ pink. Methylene blue* works via NADPH (so it fails in G6PD deficiency) |
- Co-oximetry (multi-wavelength spectrophotometry) on arterial or venous blood โ pulse oximetry is unreliable*
- Analyze promptly โ MetHb levels change on standing*
- Sulfhemoglobin also causes cyanosis but is not reversed by reducing agents*
2.5 Rapoport-Luebering Pathway & 2,3-BPG
| Feature | Details |
|---|---|
| Reaction | 1,3-BPG โ 2,3-BPG (bisphosphoglycerate mutase) โ 3-PG (bisphosphoglycerate phosphatase), bypassing phosphoglycerate kinase |
| Function | 2,3-BPG (2,3-DPG) competes for the Oโ-binding site of Hb โ โ HbโOโ affinity โ โ Oโ delivery to tissues (right shift) |
| ATP cost | Skips the PGK step โ the cell loses the 2 ATP that step would make; net ATP from that glucose can drop toward zero โ ATP deficit |
| Regulation | Acidic pH and low 3-PG/2-PG inhibit the mutase; acidic pH and low ATP activate the phosphatase โ both push 1,3-BPG back toward ATP production |
| Increased 2,3-BPG | High altitude, anemia, hypoxia (adaptive โ more Oโ unloaded) |
| Clinical significance | Deficient pathway โ โ Oโ affinity โ tissue hypoxia โ compensatory erythrocytosis. Stored blood loses 2,3-BPG* |
2.6 Four Pathways at a Glance
| Pathway | % Glucose | Key Enzyme | Product | Protects / Provides | Defect โ Disease |
|---|---|---|---|---|---|
| Embden-Meyerhof | ~90% | PK, PFK, hexokinase | ATP (net 2) | Energy for pumps, shape, flippases | PK deficiency โ hemolytic anemia |
| Hexose monophosphate | 5โ10% | G6PD | NADPH โ GSH | Oxidant protection of Hb and membrane | G6PD deficiency โ Heinz body hemolysis |
| Methemoglobin reductase | Branch of EMP | Cytochrome b5 reductase | Uses NADH | Iron kept Feยฒโบ | Methemoglobinemia โ cyanosis |
| Rapoport-Luebering | Branch of EMP | BPG mutase | 2,3-BPG | Oโ release to tissues | โ Oโ affinity โ hypoxia/erythrocytosis |
2.7 RBC Deformability
| Feature | Details |
|---|---|
| Numbers | Biconcave; volume ~90 fL; surface area ~140 ยตmยฒ = ~40% more surface than a 90 fL sphere; stretches up to 2.5ร resting diameter; passes ~2 ยตm splenic pores (McKenzie: ~3 ยตm) and capillaries |
| Membrane properties | ~100ร more elastic than a comparable latex membrane, yet laterally stronger than steel |
| Determinants | โ Geometry (excess surface-to-volume) โก Cytoplasmic viscosity (MCHC 32โ36%) โข Membrane elasticity (skeleton + lipids) |
| Mechanism of loss | Aging RBCs lose membrane surface but keep Hb โ MCHC rises โ viscosity rises. MCHC >36% (spherocytes) โ can’t pass splenic pores โ removed by macrophages |
| Clinical significance | Spherocytes, sickle cells, and dehydrated cells have short survival because they can’t deform |
2.8 Membrane Lipids
| Feature | Details |
|---|---|
| Overall composition | ~52% protein, ~40% lipid, ~8% carbohydrate |
| Bilayer | Phospholipids with hydrophilic heads facing plasma and cytoplasm and hydrophobic tails hidden inside โ impermeable barrier; reseals rapidly when torn |
| Cholesterol | โ 1 molecule per phospholipid, equally in both leaflets; confers tensile strength. โ cholesterol โ stronger but less elastic |
| Cholesterol exchange | Continuous exchange with plasma lipoproteins (RBC can’t synthesize lipid); affected by plasma bile salts and LCAT. Abnormal cholesterol content/distribution โ acanthocytes and target cells (liver disease) |
| Phospholipid asymmetry | Outer: PC, SM ยท Inner: PS, PE (+ PI). Maintained by energy-dependent flippases, floppases, scramblases |
| PS exposure | PS (the only negatively charged phospholipid) flips to the outer layer in senescent RBCs, sickle cell anemia, thalassemia โ macrophage PS receptors โ destruction |
| Glycolipids | ~5% of outer leaflet; carbohydrate chains form the negatively charged glycocalyx (prevents adhesion, protects from microbes); carry ABH and Lewis antigens |
| Leaflet imbalance (McKenzie) | Outer leaflet expansion โ echinocytes ยท inner leaflet expansion โ stomatocytes |
2.9 Transmembrane (Integral) Proteins
| Protein | Function | Blood Group / Note |
|---|---|---|
| Band 3 (anion exchanger 1) | Clโป/HCOโโป exchange; most abundant transmembrane protein (~27% of protein, ~1.2 million copies); anchors ankyrin complex | Carries most ABH determinants; Diego |
| Glut-1 (band 4.5) | Glucose transport (no energy) | Supports ABH antigens |
| Glycophorin A (PAS-1) | ~85% of glycophorins; sialic acid โ negative charge | MN |
| Glycophorin B (PAS-4) | ~10% of glycophorins | Ss (with GPA = MNSs system) |
| Glycophorin C (PAS-2) | ~4%; links to protein 4.1 complex | Gerbich |
| Rh proteins | Multipass (12ร) lipoproteins | D and CcEe antigens |
| RhAG | Required for Rh antigen expression; probable COโ gas transporter | Loss โ Rh-null with morphologic abnormalities (stomatocytes)* |
| Kell | Znยฒโบ-binding endopeptidase | Kell antigens (XK protein nearby) |
| Duffy | G-proteinโcoupled (chemokine) receptor | Duffy antigens |
| Kidd | Urea transporter | Kidd antigens |
| Aquaporin 1 | Water channel | Colton* |
| Pumps & cotransporters | Naโบ/Kโบ-ATPase, Caยฒโบ-ATPase, Kโบ-Clโป, Naโบ-Kโบ-2Clโป etc. | Osmotic balance |
| ICAM-4, CD47 | Adhesion; CD47 ‘don’t eat me’/signal receptor | LW (ICAM-4) |
Transmembrane proteins cluster into two complexes named by their skeletal anchor: the ankyrin complex (band 3, protein 4.2, RhAG, Rh, GPA, CD47, LW) and the 4.1 complex (band 3, Rh, Duffy, Kell/XK, GPC, Glut-1 + dematin, adducin, actin, tropomyosin, tropomodulin). These are the vertical connections.
2.10 GPI Anchor & PNH
| Feature | Details |
|---|---|
| Structure | Phosphatidylinositol (PI) in the outer leaflet + glycan core โ glycosylphosphatidylinositol (GPI) anchor |
| Proteins held | >30, including CD55 (DAF, decay-accelerating factor) and CD59 (MIRL, membrane inhibitor of reactive lysis) โ both protect against complement |
| Gene | PIGA encodes a glycosyltransferase needed early in GPI synthesis |
| Mechanism of disease | Acquired PIGA mutation in a stem cell clone โ no GPI anchor โ CD55/CD59 absent โ complement-mediated intravascular hemolysis = paroxysmal nocturnal hemoglobinuria (PNH) |
| Lab diagnosis* | Flow cytometry: loss of CD55/CD59 on RBCs and FLAER/GPI-linked markers on granulocytes/monocytes (replaced the older sucrose hemolysis and Ham acid tests) |
- EDTA peripheral blood; process within the lab’s validated window (typically โค48 h)
- Granulocytes/monocytes are preferred for clone size: RBC clones are underestimated after hemolysis or transfusion (the GPI-deficient cells are lysed or diluted)
- Report RBC type II (partial) and type III (complete deficiency) populations separately
2.11 Cytoskeletal (Peripheral) Proteins
| Protein | SDS-PAGE Band | Function |
|---|---|---|
| ฮฑ-spectrin | 1 | Antiparallel heterodimer with ฮฒ-spectrin; primary skeletal protein (~16% of protein) |
| ฮฒ-spectrin | 2 | Binds ankyrin and actin/4.1 (~14%) |
| Ankyrin | 2.1 | Anchors spectrin to band 3 and protein 4.2 (ankyrin complex) |
| Adducin | 2.9 | Caps actin filaments; links to band 3 |
| Protein 4.1 | 4.1 | Stabilizes spectrinโactin junction; anchors 4.1 complex (GPC) |
| Protein 4.2 | 4.2 | Strengthens ankyrinโband 3 binding |
| Dematin | 4.9 | Actin bundling; links to Glut-1 |
| Actin | 5 | Short filaments of 14โ16 monomers; binds ฮฒ-spectrin |
| Tropomodulin | 5 | Caps actin filaments |
| G3PD | 6 | Glycolytic enzyme bound to membrane |
| Tropomyosin | 7 | Regulates actin filament length |
Spectrin heterodimers (ฮฑ + ฮฒ, antiparallel) join head-to-head into tetramers, and tetramer tails meet at actinโ4.1 junctional complexes, forming a hexagonal lattice just under the bilayer โ the horizontal (lateral) support. During deformation spectrin dimer bonds open and close and its helical repeats unfold and refold, then spring back.
| Linkage | Proteins Involved | Defect โ Disease | Mechanism |
|---|---|---|---|
| Vertical (bilayer โ skeleton) | Band 3, ankyrin, protein 4.2, ฮฑ/ฮฒ-spectrin (spectrinโankyrinโband 3) | Hereditary spherocytosis (mostly autosomal dominant) | Too few anchors โ lipid bilayer lost as small blebs/vesicles, volume kept โ โ surface-to-volume โ spherocyte |
| Horizontal (within skeleton) | Spectrin dimerโdimer bonds, spectrinโankyrinโ4.1 junction | Hereditary elliptocytosis (ovalocytosis; autosomal dominant) | Membrane fails to rebound after deformation โ cells progressively elongate; mild to severe hemolysis |
- Osmotic fragility: fresh heparinized blood; spherocytes lyse in less-hypotonic saline (โ fragility); incubated (24 h, 37 ยฐC) test increases sensitivity; results falsely normal after transfusion or with many retics
- EMA (eosin-5โฒ-maleimide) binding by flow cytometry: โ fluorescence in HS (EMA binds band 3); EDTA blood, stable several days refrigerated
- SDS-PAGE of membrane proteins (reference labs): Coomassie blue stains proteins, PAS stains glycophorins; lower band number = higher molecular weight
2.12 Osmotic Balance & Permeability
| Feature | Details |
|---|---|
| Permeable to | Water (via aquaporin 1) and anions HCOโโป and Clโป (via band 3) |
| Impermeable to | Naโบ, Kโบ, Caยฒโบ and large molecules (proteins) โ the membrane is semipermeable |
| Gradients | Intracellular : extracellular Naโบ 1 : 12 and Kโบ 25 : 1 (McKenzie: RBC Naโบ 5.4โ7 vs plasma 135โ145; RBC Kโบ 98โ106 vs plasma 3.6โ5.0 mmol/L). Intracellular Caยฒโบ only 5โ10 ยตmol/L |
| Pumps | ATP-dependent Naโบ-ATPase / Kโบ-ATPase (Naโบ/Kโบ pump: 3 Naโบ out, 2 Kโบ in) ยท Caยฒโบ-ATPase (controlled by calmodulin; needs Mgยฒโบ) ยท pumps use ~15% of RBC ATP |
| Mechanism of failure | ATP loss or pump damage โ Caยฒโบ and Naโบ influx โ water follows โ cell swells โ spheroid โ ruptures = colloid osmotic hemolysis |
| Calcium | โ Caยฒโบ โ cross-links skeletal proteins (rigid cells, e.g., irreversibly sickled cells) and opens the Gรกrdos Kโบ channel โ Kโบ and water loss โ dehydration (McKenzie) |
| Clinical example | Sickle cell disease: crystallized HbS deforms the membrane โ โ Naโบ, Kโบ, especially Caยฒโบ permeability โ hemolysis |
- Because RBC Kโบ is ~25ร plasma Kโบ, in-vitro hemolysis falsely raises serum potassium โ check the hemolysis index before reporting
- Delayed separation or refrigerated whole blood lets Kโบ leak out of cells (pumps stop without glucose/warmth)*
*From general hematology/laboratory practice, not stated in the Rodak Ch. 9 or McKenzie source pages.
3 ยท Visual Memory Hooks
โEvery Hungry Man Runsโ โ EMP = Energy (ATP) ยท HMP = Hero against oxidants (NADPH) ยท MetHb reductase = Maintains Feยฒโบ (NADH) ยท R-L = Releases Oโ (2,3-BPG).
โP for Protection, H for Hemeโ โ NADPH from HMP Protects via glutathione; NADH from glycolysis fixes Heme iron via MetHb reductase.
โSpend 2, Earn 4, Keep 2โ โ hexokinase + PFK spend; PGK + PK earn; net +2.
โFava, Fever, and Pharmacyโ โ fava beans, infection, oxidant drugs (primaquine, sulfa, dapsone).
โBPG = Bye-bye Precious Gasโ โ more 2,3-BPG = Hb lets Oโ go. Costs 2 ATP.
โFerric is Frozenโ โ Feยณโบ can’t carry Oโ โ blue patient, brown blood; Vitamin C thaws it.
โOxygen rides freeโ โ Oโ/COโ transport is the only listed RBC process that needs no energy.
โPC and SM Sit outside; PS and PE Party insideโ โ PS outside = ‘eat me’.
โA-MN, B-Ss, C-Gerbich (AโM, BโS, CโG)โ.
โVertical Vesicles โ Spheres; Horizontal Holds shape โ Ellipsesโ โ vertical defect = HS; horizontal defect = HE.
โBand 3 Asks Ankyrin (with 4.2) to Hug Spectrinโ โ the major vertical anchor.
โBig proteins finish firstโ โ lowest band number = heaviest protein (spectrin = bands 1, 2).
โSodium Stays Out (1:12), Potassium Parties In (25:1)โ โ pump: 3 Naโบ out, 2 Kโบ in.
โPIGA Pulls the anchor โ 55 and 59 go missingโ โ no GPI โ no CD55/CD59 โ complement lysis.
Pattern Triggers
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| Episodic hemolysis after primaquine/sulfa/fava; Heinz bodies; bite cells | G6PD deficiency (HMP shunt) | No NADPH โ no GSH โ peroxide denatures Hb |
| Chronic hemolysis, normal-shaped RBCs, no Heinz bodies, โ ATP | PK deficiency (EMP) | ATP-poor cells lose cation control, become rigid |
| Cyanosis, normal PaOโ, chocolate-brown blood; improves with vitamin C | Methemoglobinemia (cytochrome b5 reductase deficiency) | Feยณโบ Hb not reduced back to Feยฒโบ |
| Brothers (siblings) with lifelong cyanosis, normal heart and lungs | Hereditary (autosomal recessive) MetHb reductase deficiency | Inherited enzyme defect, not acquired |
| Right-shifted Oโ curve at altitude or in chronic anemia | โ 2,3-BPG | Rapoport-Luebering activity rises to unload Oโ |
| Spherocytes, โ MCHC, โ osmotic fragility, family history | Hereditary spherocytosis (vertical defect) | Lost membrane vesicles โ โ surface area |
| Elliptocytes/ovalocytes, family history | Hereditary elliptocytosis (horizontal defect) | Spectrin dimerโdimer or spectrinโ4.1 bonds weak |
| Hemoglobinuria, cytopenias, thrombosis; CD55/CD59-negative cells | PNH | Acquired PIGA mutation โ no GPI anchor |
| Rh-null phenotype with abnormal RBC shape | RhAG absence | RhAG required for Rh antigen expression |
| Target cells / acanthocytes in liver disease | Membrane cholesterol imbalance | Lipid exchange with abnormal plasma |
| Very high Kโบ in a hemolyzed sample | In-vitro hemolysis artifact | RBC Kโบ is ~25ร plasma |
Commonly Confused Pairs
| Feature | A | B |
|---|---|---|
| NADPH vs NADH | HMP (G6PD) โ glutathione โ peroxide detox | EMP (G3PD) โ MetHb reductase โ Feยณโบ โ Feยฒโบ |
| HMP vs MetHb reductase | Prevents oxidation | Reverses oxidation of heme iron |
| Integral vs peripheral | Glycophorin A, band 3, Rh, Glut-1 (cross the bilayer) | Spectrin, ankyrin, actin, 4.1, 4.2 (under the bilayer) |
| Vertical vs horizontal | Spectrinโankyrinโband 3โ4.2 โ HS | Spectrinโspectrin, spectrinโactinโ4.1 โ HE |
| Aerobic vs anaerobic glycolysis (Rodak terms) | Aerobic = HMP (oxidative) | Anaerobic = EMP (ATP) |
| Cholesterol โ vs โ | Stronger, less elastic | More elastic, less tensile strength |
| CD55 vs CD59 | DAF โ accelerates decay of C3/C5 convertases | MIRL โ blocks membrane attack complex |
| Coomassie vs PAS on SDS-PAGE | Stains most proteins | Stains glycophorins (carbohydrate-rich) |
| Colloid osmotic hemolysis vs Gรกrdos dehydration | Naโบ/water in โ swelling โ lysis | Caยฒโบ โ Kโบ/water out โ dense, dehydrated cell |
Timeline & Kinetics Table
| Marker / Event | Onset | Peak | Duration | Best Exam Use |
|---|---|---|---|---|
| Loss of ribosomes & mitochondria | After marrow release | โ | 24โ48 h | Why mature RBCs rely on glycolysis only |
| HMP activity under oxidant stress | Immediate | Up to ~30ร baseline | While stress persists | Reserve capacity; fails in G6PD deficiency |
| Hemolysis after oxidant drug in G6PD deficiency* | ~1โ3 days | โ | Often self-limited as old cells are cleared | Why testing during crisis can be falsely normal |
| Methemoglobin formation | Continuous (~2%/day) | 20โ40% if unreduced | โ | Size of the daily reducing workload |
| Lipid lateral redistribution | Within ~100 ms of stress | โ | โ | How the membrane deforms at a capillary |
| Enzyme decline โ senescence | Throughout life span | โ | ~120 days | Why RBCs die |
4 ยท Diagnostic Flowcharts
Flowchart 1 โ Hereditary hemolytic anemia: enzyme or membrane?
| Chronic/episodic hemolysis (โ retic, โ indirect bili, โ Hp), DAT negative | โ | Look at the smear |
| Spherocytes, โ MCHC, family history | โ | Membrane โ vertical defect โ HS |
| Elliptocytes/ovalocytes | โ | Membrane โ horizontal defect โ HE |
| Normal shape; hemolysis triggered by drug/infection; Heinz bodies, bite cells | โ | Enzyme โ HMP โ G6PD deficiency |
| Normal shape; chronic hemolysis; no oxidant trigger | โ | Enzyme โ EMP โ PK deficiency (nonspherocytic) |
| โ ๏ธ Common mistake: calling every hereditary hemolysis ‘spherocytosis’. Enzyme defects typically give nonspherocytic hemolytic anemia. | ||
Flowchart 2 โ Cyanosis with normal lungs and heart
| Blue skin, PaOโ normal, SpOโ low, brown blood | โ | Measure MetHb by co-oximetry |
| โ MetHb + new oxidant drug/chemical | โ | Acquired methemoglobinemia |
| โ MetHb since birth, affected sibling | โ | Hereditary cytochrome b5 reductase deficiency |
| Responds to vitamin C (reducing agent) | โ | Confirms reducible MetHb |
| Cyanosis not reversible, abnormal spectrum | โ | Consider sulfhemoglobin or Hb M variant* |
| โ ๏ธ Common mistake: choosing the HMP shunt (NADPH) as the pathway that reduces MetHb. The main pathway uses NADH via cytochrome b5 reductase. | ||
Flowchart 3 โ Timing: when to test enzymes after hemolysis
| Suspected G6PD or PK deficiency during acute hemolysis | โ | Note retic count and transfusion history |
| High retic or recent transfusion | โ | Enzyme level may be falsely normal (young/donor cells)* |
| Screen normal but strong clinical suspicion | โ | Repeat ~2โ3 months after recovery / transfusion* |
| Screen low (no fluorescence) | โ | Confirm with quantitative assay โ deficiency |
| โ ๏ธ Common mistake: trusting a normal G6PD result drawn in the middle of a hemolytic crisis. | ||
Flowchart 4 โ Method selection for a suspected membrane disorder*
| Spherocytes on smear, DAT negative | โ | Rule out immune hemolysis first (DAT) |
| Need a screening test for HS | โ | Osmotic fragility (ยฑ incubated) or EMA binding by flow |
| Need to identify the defective protein | โ | SDS-PAGE of membrane proteins (reference lab) / molecular testing |
| Hemoglobinuria + cytopenias | โ | Not a structural membrane defect โ PNH flow (CD55/CD59, FLAER) |
| โ ๏ธ Common mistake: diagnosing HS from osmotic fragility alone when spherocytes could be immune (warm AIHA) โ the DAT separates them. | ||
Flowchart 5 โ Why is this cell swelling and lysing?
| Glucose deprivation or glycolytic enzyme defect | โ | โ ATP |
| โ ATP | โ | Naโบ/Kโบ and Caยฒโบ pumps fail (they normally use ~15% of ATP) |
| Naโบ and Caยฒโบ enter, water follows | โ | Cell swells โ sphere โ loses deformability |
| Spheres trapped in spleen or rupture | โ | Colloid osmotic hemolysis |
| โ ๏ธ Common mistake: thinking RBCs need ATP to carry oxygen. They need it to survive (pumps, shape), not for Oโ binding. | ||
5 ยท 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | Mature RBCs lack mitochondria and depend entirely on anaerobic glycolysis for ATP. |
| 2 | Glucose enters the RBC through Glut-1 without energy expenditure or insulin. |
| 3 | Oxygen and COโ transport by hemoglobin does not require energy. |
| 4 | The Embden-Meyerhof pathway consumes 2 ATP and generates 4, for a net gain of 2 ATP per glucose. |
| 5 | Hexokinase and phosphofructokinase are the ATP-consuming, rate-limiting steps of glycolysis. |
| 6 | Pyruvate kinase is activated allosterically by fructose-1,6-bisphosphate. |
| 7 | Glycolytic enzyme deficiencies cause hereditary nonspherocytic hemolytic anemia. |
| 8 | About 5โ10% of glucose-6-phosphate enters the HMP shunt at rest, rising up to 30-fold under oxidative stress. |
| 9 | G6PD is the only source of NADPH in the RBC. |
| 10 | NADPH keeps glutathione reduced so glutathione peroxidase can detoxify hydrogen peroxide. |
| 11 | G6PD deficiency is the most common inherited RBC enzyme deficiency worldwide. |
| 12 | Methemoglobin contains ferric (Feยณโบ) iron and cannot carry oxygen. |
| 13 | Cytochrome b5 reductase uses NADH from glycolysis and provides over 65% of methemoglobin-reducing capacity. |
| 14 | The Rapoport-Luebering pathway forms 2,3-BPG, which lowers hemoglobinโoxygen affinity and increases Oโ delivery. |
| 15 | Diverting 1,3-BPG to 2,3-BPG sacrifices 2 ATP. |
| 16 | The RBC membrane is about 52% protein, 40% lipid, and 8% carbohydrate. |
| 17 | The RBC has about 40% more surface area than a sphere of equal volume, allowing deformation. |
| 18 | MCHC above 36% increases viscosity and reduces deformability. |
| 19 | Phosphatidylcholine and sphingomyelin are in the outer leaflet; phosphatidylserine and phosphatidylethanolamine are in the inner leaflet. |
| 20 | Exposure of phosphatidylserine on the outer leaflet signals macrophages to destroy the RBC. |
| 21 | Band 3 is the most abundant transmembrane protein and exchanges chloride for bicarbonate. |
| 22 | Glycophorin A carries MN, glycophorin B carries Ss, and glycophorin C carries Gerbich antigens. |
| 23 | Vertical linkage defects (band 3, ankyrin, protein 4.2, spectrin) cause hereditary spherocytosis; horizontal defects cause hereditary elliptocytosis. |
| 24 | Naโบ/Kโบ and Caยฒโบ pumps keep RBC Kโบ high and Naโบ and Caยฒโบ low; ATP failure causes colloid osmotic hemolysis. |
| 25 | An acquired PIGA mutation prevents GPI anchor synthesis, leading to CD55/CD59 loss and paroxysmal nocturnal hemoglobinuria. |
Match product to pathway to disease: ATP โ EMP โ PK deficiency ยท NADPH โ HMP โ G6PD deficiency (Heinz bodies) ยท NADH โ MetHb reductase โ methemoglobinemia (cyanosis) ยท 2,3-BPG โ Rapoport-Luebering โ Oโ affinity. For the membrane: vertical = spherocytes, horizontal = elliptocytes.
Quick Interpretation Table
| Lab Finding | Clinical Interpretation |
|---|---|
| G6PD fluorescent spot test: no fluorescence | G6PD deficiency (no NADPH produced) |
| Heinz bodies on supravital stain + bite cells | Oxidant hemolysis (HMP failure) |
| โ MetHb on co-oximetry, cyanosis, normal PaOโ | Methemoglobinemia |
| Spherocytes + โ osmotic fragility + DAT negative | Hereditary spherocytosis (vertical defect) |
| Elliptocytes > 25% of RBCs, family history* | Hereditary elliptocytosis (horizontal defect) |
| RBCs/granulocytes lacking CD55 and CD59 by flow | PNH (GPI anchor deficiency) |
| Falsely high Kโบ with visible hemolysis | In-vitro hemolysis โ recollect |
๐ด Flashcards โ Active Recall Practice
๐ Practice Quiz โ Test Your Knowledge
๐ชค Trap Questions โ Beat the Examiner
8 ยท Rapid Revision Sheet
Glycolysis (EMP)
- ~90% glucose ยท net 2 ATP (โ2 +4)
- Spend: hexokinase, PFK
- Earn: PGK, PK
- PK โ F1,6-BP
- Defect โ nonspherocytic HA (PK)
HMP Shunt
- 5โ10% ยท up to 30ร under stress
- G6PD โ NADPH (only source)
- NADPH โ GSH โ peroxide โ HโO
- Defect โ Heinz bodies, bite cells
- Spot test: no fluorescence
MetHb & 2,3-BPG
- b5 reductase + NADH โ Feยฒโบ (>65%)
- MetHb 2%/day ยท 20โ40% if unreduced
- Cyanosis ยท brown blood ยท vitamin C
- BPG mutase โ 2,3-BPG โ right shift
- Costs 2 ATP ยท โ at altitude/anemia
Deformability Numbers
- ~90 fL ยท 140 ยตmยฒ ยท +40% surface
- Stretch 2.5ร ยท pores ~2โ3 ยตm
- MCHC 32โ36% ยท >36% = rigid
- 52% protein ยท 40% lipid ยท 8% CHO
Lipids
- Outer: PC, SM ยท Inner: PS, PE
- PS out = eat me (senescent, SCD, thal)
- Cholesterol โ 1:1 phospholipid, both leaflets
- โ cholesterol: strong, less elastic
- Glycolipids: ABH, Lewis
Transmembrane Proteins
- Band 3: Clโป/HCOโโป, most abundant
- GPA MN ยท GPB Ss ยท GPC Gerbich
- RhAG โ Rh-null ยท Kidd = urea
- Glut-1 glucose ยท aquaporin 1 water
- Duffy = chemokine receptor
Skeleton
- Bands 1/2 = ฮฑ/ฮฒ spectrin ยท 2.1 ankyrin
- 4.1 junction ยท 4.2 ankyrin helper ยท 5 actin
- Vertical: spectrinโankyrinโband 3โ4.2 โ HS
- Horizontal: spectrinโspectrin, spectrinโactinโ4.1 โ HE
- Low band # = high MW
Osmotic Balance
- Naโบ in:out 1:12 ยท Kโบ 25:1
- Caยฒโบ 5โ10 ยตmol/L (calmodulin)
- Na/K pump 3 out / 2 in
- Pumps = 15% of ATP
- โ ATP โ colloid osmotic hemolysis
Confusing Pairs
- NADPH (HMP) โ NADH (MetHb reductase)
- Prevent oxidation (HMP) โ reverse (b5R)
- Integral (GPA) โ peripheral (ankyrin)
- CD55 DAF โ CD59 MIRL
- Coomassie proteins โ PAS glycophorins
Associations
- PIGA โ no GPI โ PNH
- Sulfa/primaquine/fava โ G6PD
- Blue brothers โ b5R deficiency
- Liver disease โ target cells
- Sickle โ Caยฒโบ โ dehydration
9 ยท Final Memory Map
- โ๏ธ RBC METABOLISM & MEMBRANE
- Energy Needs
- No mitochondria โ anaerobic glycolysis only
- Glut-1 glucose entry (no insulin)
- Oโ transport needs no energy
- Embden-Meyerhof
- Net 2 ATP ยท hexokinase/PFK spend, PGK/PK earn
- PK deficiency โ nonspherocytic HA
- Shunts
- HMP: G6PD โ NADPH โ GSH โ Heinz bodies if deficient
- MetHb reductase: NADH + b5 reductase โ Feยฒโบ; cyanosis if deficient
- Rapoport-Luebering: 2,3-BPG โ Oโ release, costs 2 ATP
- Membrane Lipids
- 52/40/8 ยท cholesterol strength vs elasticity
- Outer PC/SM ยท inner PS/PE ยท PS out = eat me
- Glycolipids ABH/Lewis ยท target cells in liver disease
- Membrane Proteins
- Transmembrane: band 3, glycophorins, Rh/RhAG, Kell, Duffy, Kidd, Glut-1
- Ankyrin complex + 4.1 complex = vertical
- GPI: CD55/CD59 ยท PIGA โ PNH
- Skeleton
- ฮฑ/ฮฒ spectrin tetramers ยท hexagonal lattice
- Vertical defect โ HS ยท Horizontal defect โ HE
- SDS-PAGE: Coomassie / PAS
- Osmotic Balance
- Water + anions pass ยท cations blocked
- Naโบ 1:12 ยท Kโบ 25:1 ยท pumps use 15% ATP
- ATP loss โ colloid osmotic hemolysis ยท Caยฒโบ โ dehydration
- Energy Needs